Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 12, 2008, Pages 5526-5531

  Liou, Gregory I ^a   Auchampach, John A ^b   Hillard, Cecilia J ^b   Zhu, Gu ^a   Yousufzai, Bilal ^a   Mian, Salman ^a   Khan, Sohail ^a   Khalifa, Yousuf ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CANNABIDIOL; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; LIPOPOLYSACCHARIDE; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; MESSENGER RNA; NUCLEOSIDE TRANSPORTER;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; RETINA CELL; RETINITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; RETINA; SALMONELLA ENTERICA; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CANNABIDIOL; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; LIPOPOLYSACCHARIDES; MALE; MICROGLIA; NUCLEOSIDE TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALMONELLA ENTERICA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58149269741     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2196     Document Type: Article

References (31)

1. Saidel MA, Berreen J, Margolis TP. Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient. Am J Ophthalmol. 2005;140:1141-1143. (Pubitemid 41821313)
2. Keino H, Takeuchi M, Usui Y, et al. Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis. Br J Ophthalmol. 2007;91:105-110. (Pubitemid 46094020)
3. Tezel G, Yang X, Luo C, Peng Y, Sun SL, Sun D. Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia. Invest Ophthalmol Vis Sci. 2007;48:705-714. (Pubitemid 351260704)
4. Theodossiadis PG, Markomichelakis NN, Sfikakis PP. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. Retina. 2007;27:399-413.
5. El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai N-J, Caldwell RB, Liou GI. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol. 2006;168:235-244. (Pubitemid 43062576)
6. Noma H, Funatsu H, Yamasaki M, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005;140:256-261. (Pubitemid 41125805)
7. Frangogiannis NG, Shimoni S, Chang SM, et al. Evidence for an active inflammatory process in the hibernating human myocardium. Am J Pathol. 2002;160:1425-1433. (Pubitemid 34411645)
8. Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol. 2007;81:1345-1351.
9. Wang AL, Yu AC, Lau LT, et al. Minocycline inhibits LPS-induced retinal microglia activation. Neurochem Int. 2005;47:152-158. (Pubitemid 40848704)
10. Medana IM, Chan-Ling T, Hunt NH. Redistribution and degeneration of retinal astrocytes in experimental murine cerebral malaria: relationship to disruption of the blood-retinal barrier. Glia. 1996;16:51-64. (Pubitemid 26350511)
11. Collis MG, Hourani SM. Adenosine receptor subtypes. Trends Pharmacol Sci. 1993;14:360-366.
12. Haskó G, Pacher P, Vizi ES, Illes P. Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci. 2005;26:511-516. (Pubitemid 41338561)
13. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:413-492.
14. Moser GH, Schrader J, Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol. 1989;256:C799-C806.
15. Noji T, Takayama M, Mizutani M, et al. KF24345, an adenosine uptake inhibitor, suppresses lipopolysaccharide-induced tumor necrosis factor-α production and leukopenia via endogenous adenosine in mice. J Pharmacol Exp Ther. 2002;300:200-205. (Pubitemid 34028528)
16. Carrier EJ, Auchampach JA, Hillard CJ. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci U S A. 2006;103:7895-7900.
17. El-Remessy AB, Khalil IE, Matragoon S, et al. Neuroprotective effect of (-)Δ9-tetrahydrocannabinol and cannabidiol in NMDA-induced retinal neurotoxicity: involvement of peroxynitrite. Am J Pathol. 2003;163:1997-2008. (Pubitemid 37310030)
18. 2B but not the A3 adenosine receptor. J Pharmacol Exp Ther. 2006;317:172-180.
19. Poulaki V, Iliaki E, Mitsiades N, et al. Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis. FASEB J. 2007;21:2113-2123. (Pubitemid 47026447)
20. Howlett AC, Barth F, Bonner TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2004;54:161-202. (Pubitemid 34575709)
21. Hampson AJ, Grimald M, Axelrod J, Wink D. Cannabidiol and (-)Δ9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci U S A. 1998;95:8268-8273. (Pubitemid 28326102)
22. 3 receptors in microglia cells. J Neurochem. 2004;86:1051-1054.
23. 3 receptor-induced CCL2 synthesis in cultured mouse astrocytes. Glia. 2004;46:410-418.
24. Yang P, de Vos AF, Kijlstra A. Macrophages in the retina of normal Lewis rats and their dynamics after injection of lipopolysaccharide. Invest Ophthalmol Vis Sci. 1996;37:77-85. (Pubitemid 26036519)
25. Hirai K, Ashraf M. Modulation of adenosine effects in attenuation of ischemia and reperfusion injury in rat heart. J Mol Cell Cardiol. 1998;30:1803-1815. (Pubitemid 28430194)
26. Kong W, Engel K, Wang J. Mammalian nucleoside transporters. Curr Drug Metab. 2004;5:63-84.
27. Belgrave BE, Bird KD, Chesher GB, et al. The effect of cannabidiol, alone and in combination with ethanol, on human performance. Psychopharmacology (Berlin). 1979;64:243-246.
28. Cunha JM, Carlini EA, Pereira AE, et al. Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology. 1980;21:175-185.
29. Mackey JR, Baldwin SA, Young JD, Cass CE. Nucleoside transport and its significance for anticancer drug resistance. Drug Resist Update. 1998;1:310-324.
30. Baldwin SJ, Mackey JR, Cass CE, Young JD. Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today. 1999;5:216-224.
31. Gordon AS, Nagy L, Mochly-Rosen D, Diamond I. Chronic ethanol-induced heterologous desensitization is mediated by changes in adenosine transport. Biochem Soc Symp. 1990;56:117-136. (Pubitemid 20295558)